Company: OCEA
Filing Date: 2025-02-26
Form Type: DEF 14A
Source: 0001493152-25-008279
Chunk: 58

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-26
Form: DEF 14A
Chunk 58
---
 one set of these materials be delivered in the future.

| 49 |

WHERE YOU CAN FIND MORE INFORMATION

We are required to file annual, quarterly, and current reports, or other information with the SEC as provided by the Securities Exchange Act of 1934, as amended. These reports contain additional information about the Company’s SEC filings are made available electronically to the public at the SEC’s website located at www.sec.gov. In addition, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act may be accessed free of charge through our website as soon as reasonably practicable after we have electronically filed such material with, or furnished it to, the SEC. The address of our website is www.oceanbiomedical.com.

OTHER MATTERS

The Company knows of no other matters to be submitted to the stockholders at the Annual Meeting, other than the proposals referred to in this Proxy Statement. If any other matters properly come before the stockholders at the Annual Meeting, it is the intention of the proxy holders to vote the shares represented thereby on such matters in accordance with their best judgment.

| By                               
 Order of the Board of Directors, |
| /s/                              
 Chirinjeev Kathuria              |
| Chirinjeev                       
 Kathuria                         |
| Chairman                         
 of the Board                     |
| January                          
 __, 2025                         |
| Providence,                      
 Rhode Island                     |

| 50 |

EXHIBIT 1

2024 Equity Incentive Plan

2025 EQUITY INCENTIVE PLAN

1. Purpose of the Plan. This 2025 Equity Incentive Plan (the “ Plan”) is intended as an incentive, to retain in the employ of and as directors, officers, consultants, advisors and employees to Ocean Biomedical, Inc. a Delaware corporation (the “ Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Internal Revenue Code of 1986, as amended (the “ Code”), persons of training, experience and ability, to attract new directors, officers, consultants, advisors and employees whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its Subsidiaries.

It is further intended that certain options granted pursuant to the